Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
about
The Link Between Periodontitis and Rheumatoid Arthritis: A Periodontist's PerspectiveIdentification of novel cholesteatoma-related gene expression signatures using full-genome microarraysCollagen-coated polycaprolactone microparticles as a controlled drug delivery system.Anti-inflammatory Actions of Adjunctive Tetracyclines and Other Agents in Periodontitis and Associated Comorbidities.Efficacy of horse chestnut leaf extract ALH-L1005 as a matrix metalloproteinase inhibitor in ligature-induced periodontitis in canine model.Genetic polymorphisms and sepsis in premature neonates.A novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: initial observations.Aggressive periodontitis: how does an understanding of the pathogenesis affect treatment?Effects of low-dose doxycycline and bisphosphonate clodronate on alveolar bone loss and gingival levels of matrix metalloproteinase-9 and interleukin-1β in rats with diabetes: a histomorphometric and immunohistochemical study.Acute actions and novel targets of matrix metalloproteinases in the heart and vasculatureThe paradox of matrix metalloproteinases in infectious disease.Periodontitis and rheumatoid arthritis: a review.Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicineClinical relevance of the host responses of periodontitis.Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation.Diagnosis and anti-infective therapy of periodontitis.Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendationsPotential oral health benefits of cranberry.Synthesis and antibacterial activity of doxycycline neoglycosides.A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases: a literature review.4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammationMatrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix.Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseasesLong-term efficacy of subantimicrobial-dose doxycycline as an adjunctive treatment to scaling and root planing: a systematic review and meta-analysis.Update of antibiotic trials for secondary prevention of coronary heart disease.Doxycycline blocks gastric ulcer by regulating matrix metalloproteinase-2 activity and oxidative stress.Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases.The Role of Proteinase-Activated Receptors 1 and 2 in the Regulation of Periodontal Tissue Metabolism and Disease.Modulation of matrix metalloproteinase and cytokine production by licorice isolates licoricidin and licorisoflavan A: potential therapeutic approach for periodontitis.Low-dose doxycycline inhibits bone resorption associated with apical periodontitis.Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleeding.Dual effect of flurbiprofen on cell proliferation and agonist-induced Ca(2+) movement in human osteosarcoma cells.Characterization of the release profile of doxycycline by PLGA microspheres adjunct to non-surgical periodontal therapy.The effect of adjunctive low-dose doxycycline and licorice therapy on gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.Decrease of MMP-9 activity improves soleus muscle regeneration[Drug release of coated dental implant neck region to improve tissue integration].Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR.Doxycycline speeds up healing of chronic venous ulcers.Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats.Doxycycline may reduce the incidence of aneurysms in haemodialysis vascular accesses.
P2860
Q26827463-54639DBE-0817-4064-97A4-77860D2FBF63Q28484501-CAEB485A-294A-48C2-958B-3806366AF299Q33332637-21188DFF-4EC9-40F5-9239-5F1C47AE4E1CQ33815397-A56C21A9-6D57-4378-8A8B-7C80B023B79CQ33849006-04B8FAEE-05E9-4F2B-AD80-3DD39E8156E6Q33856680-1017FF63-FBC1-4E5A-A0FE-739405351652Q33912089-99A3A937-3FCB-4AF1-9140-CC8C785D59DEQ34086584-65742256-7372-47D5-A523-8F77EB099CBFQ34119251-64088CB3-EAB7-4766-B73B-9890C569EA68Q35995215-8D987541-851E-4887-BB6A-30811354A37BQ36264888-4224CCEE-2FD8-4C0B-BA3C-3483E85DA775Q36309246-6A0951DD-B419-49B4-B4CB-EE10E78C97F2Q36317523-A05B636A-F5DD-4469-9BF5-258460669BA6Q36703982-00A6C598-97D6-47AF-9567-B92A602EB288Q36863958-C7F046C2-DA17-40F2-9FA1-8827CE5C80A5Q36901965-F6E67393-562E-45C8-9935-8A7D0D0FB692Q37102073-DB53BB5B-4F21-4A5A-AF29-309E7E79DE76Q37229299-E3280823-886D-4E44-BF2D-3383C02D18C7Q37270510-63E7BCE3-1BB1-4491-ABB3-8F6C8528DD85Q37352658-3C6F7CE9-6DCA-4FCD-9022-D4C35E01A6FBQ37456943-CC137DC0-2BAC-4251-BEEC-315003DF5DE5Q37573155-B5B6228C-568C-4742-BD23-763D33406EAAQ37706103-1B379C4C-855A-453C-BAA3-F1BFEDD4B301Q37854591-A080D647-BDAA-42A8-A942-0A3662A8BF23Q37865389-57E16B79-F4A8-4DA9-9524-4FC6B96464FFQ38256173-BD2EC9DA-F777-487A-85DA-04B21806FC0CQ38786719-304C3DB7-2E17-465E-98AB-5A385C5D3741Q39306127-0E24108F-BFE8-497B-B822-953302B0380CQ39665753-BEB3135E-2744-4978-82E9-43258B4C7F18Q39830266-E141E3FC-9E86-4CAA-9FE8-22B2BBD0034CQ40246699-1D452EB3-429A-4475-877C-A14AF72FA2F4Q40323500-D0196289-B090-4432-AFA0-3B7BAFE25D2BQ41007903-541C3A85-7EE1-41C5-A0F4-FAF2B60ECFBFQ41763116-48BFB543-308A-403F-9870-4D90F4BDD90FQ42097678-4C0A3ECD-5EEA-429D-8547-699C2582AC44Q43266427-60C67A0D-41CD-4906-9697-6C0B62BCE2F0Q43538572-C72D858C-1B1B-45AC-872D-7CD2DCE16DCFQ43642111-7737E346-422F-4987-ACE8-B09AB413DE57Q45236701-3D6CCA9E-32A3-468E-B13B-FDB85CADCDBCQ45291392-29C82624-8C1E-47C9-96CD-20F84DA3AB13
P2860
Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Subantimicrobial dose doxycycl ...... roidal anti-inflammatory drug.
@en
Subantimicrobial dose doxycycl ...... roidal anti-inflammatory drug.
@nl
type
label
Subantimicrobial dose doxycycl ...... roidal anti-inflammatory drug.
@en
Subantimicrobial dose doxycycl ...... roidal anti-inflammatory drug.
@nl
prefLabel
Subantimicrobial dose doxycycl ...... roidal anti-inflammatory drug.
@en
Subantimicrobial dose doxycycl ...... roidal anti-inflammatory drug.
@nl
P2093
P2860
P1476
Subantimicrobial dose doxycycl ...... roidal anti-inflammatory drug.
@en
P2093
Eugene Komaroff
Gülay Tüter
Hsi-Ming Lee
Lorne M Golub
Maria E Ryan
Sebastian G Ciancio
P2860
P304
P356
10.1902/JOP.2004.75.3.453
P407
P577
2004-03-01T00:00:00Z